Purinoceptors in renal microvessels: Adenosine-activated and cytochrome P450 monooxygenase-derived arachidonate metabolites

Pharmacological Reports

Volumn 57, Issue SUPPL., 2005, Pages 191-195

  Carroll, Mairead A ^a   Cheng, Monica K ^a   Liclican, Elvira L ^a   Li, Jing ^a   Doumad, Anabel B ^a   McGiff, John C ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Adenosine 2A receptors; EETs; Kidney; Salt

Indexed keywords

2 CHLOROADENOSINE; ADENOSINE; ADENOSINE A2A RECEPTOR; ADENOSINE RECEPTOR; ARACHIDONIC ACID DERIVATIVE; CYTOCHROME P450; EPOXYGENASE; EPOXYGENASE 2C23; EPOXYICOSATRIENOIC ACID; ICOSANOID; ISOENZYME; OXYGENASE; PURINE RECEPTOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL FOOD; BLOOD VESSEL REACTIVITY; ENZYME ACTIVITY; FATTY ACID TRANSPORT; GLOMERULUS; KIDNEY BLOOD VESSEL; KIDNEY FUNCTION; KIDNEY VASCULAR RESISTANCE; MICROVASCULATURE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; RECEPTOR UPREGULATION; RENAL PROTECTION; REVIEW; SALT INTAKE; SALT LOADING;

EID: 33645670375     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Capdevila JH, Wei S, Yan J, Karara A, Jacobson HR, Falck JR, Guengerich FP, DuBois RN: Cytochrome P-450 arachidonic acid epoxygenase. Regulatory control of the renal epoxygenase by dietary salt loading. J Biol Chem, 1992, 267, 21720-21726.
2. 2A receptors. Br J Pharmacol, 2004, 141, 441-448.
3. Guimaraes S, Morato M, Sousa T, Albino-Teixeira A: Hypertension due to blockade of adenosine receptors. Pharmacol Toxicol, 2003, 92, 160-162.
4. Holla VR, Makita K, Zaphiropoulos PG, Capdevila JH: The kidney cytochrome P-450 2C23 arachidonic acid epoxygenase is upregulated during dietary salt loading. J Clin Invest, 1999, 104, 751-760.
5. Imig JD, Falck JR, Inscho EW: Contribution of cytochrome P450 epoxygenase and hydroxylase pathways to afferent arteriolar autoregulatory responsiveness. Br J Pharmacol, 1999, 127, 1399-1405.
6. Inscho EW: P2 receptors in regulation of renal microvascular function. Am J Physiol, 2001, 280, F927-F944.
7. Ito O, Roman RJ: Role of 20-HETE in elevating chloride transport in the thick ascending limb of Dahl SS/Jr rats. Hypertension, 1999, 33, 419-423.
8. Ledent C, Vaugeois JM, Schiffmann SN, Pedrazzini T, El Yacoubi M, Vanderhaeghen JJ, Costentin J et al.: Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptror. Nature, 1997, 388, 674-678.
9. Liclican EL, McGiff JC, Pedraza PL, Ferreri NR, Falck JR, Carroll MA: Exaggerated response to adenosine in kidneys from high salt-fed rats: role of epoxyeicosatrienoic acids. Am J Physiol, 2005, 289, F386-F392.
10. Makita K, Takahashi K, Karara A, Jacobson HR, Falck JR, Capdevila JH: Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet, J Clin Invest, 1999, 94, 2414-2420.
11. Navar LG, Inscho EW, Majid SA, Imig JD, Harrison-Bernard LM, Mitchell KD: Paracrine regulation of the renal microcirculation. Physiol Rev, 1996, 76, 425-536.
12. 2a receptors on renal microvascular reactivity. Am J Physiol, 2001, 280, F406-F414.
13. Node Y, Huo Y, Ruan X, Yang B, Spiecker M, Ley K, Zeldin DC, Liao JK: Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science, 1999, 285, 1276-1279.
14. 2A adenosine receptor: a novel therapeutic target in renal disease. Am J Physiol, 2002, 282, F10-F18.
15. 1 receptors: effect of dietary sodium chloride. Eur J Pharmacol, 1999, 384, 71-79.
16. Zhao X, Inscho EW, Bondlela M, Falck JR, Imig JD: The CYP450 hydroxylase pathway contributes to P2X receptor-mediated afferent arteriolar vasoconstriction. Am J Physiol, 2001, 281, H2089-H2096.